Gilead Sciences Inc. [GILD] moved down -1.18: Why It’s Important

Gilead Sciences Inc. [NASDAQ: GILD] price plunged by -1.18 percent to reach at -$1.05. The company report on December 1, 2022 that Gilead Sciences: All Stars Project Empowers Youth Through Performance.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…


Dancing has always been a part of Shadae McDaniel’s life. When she was part of an ensemble, she and her fellow dancers would rehearse their routines over and over, trying to ensure they were ready for the stage.

“When you’re on stage it’s a completely different experience than in the studio. You’re scared. You’re nervous,” says Shadae, Vice President and City Leader of the All Stars Project of New Jersey. “It doesn’t matter how many times you’ve rehearsed. It always feels new, but you figure out how to connect with other people on stage.”.

A sum of 6761014 shares traded at recent session while its average daily volume was at 8.45M shares. Gilead Sciences Inc. shares reached a high of $89.10 and dropped to a low of $87.47 until finishing in the latest session at $87.98.

The one-year GILD stock forecast points to a potential downside of -6.37. The average equity rating for GILD stock is currently 2.50, trading closer to a bullish pattern in the stock market.

Guru’s Opinion on Gilead Sciences Inc. [GILD]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for GILD shares is $82.71 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on GILD stock is a recommendation set at 2.50. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Barclays have made an estimate for Gilead Sciences Inc. shares, keeping their opinion on the stock as Equal Weight, with their previous recommendation back on October 31, 2022. While these analysts kept the previous recommendation, Truist raised their target price from $76 to $91. The new note on the price target was released on October 28, 2022, representing the official price target for Gilead Sciences Inc. stock. Previously, the target price had yet another raise from $79 to $96, while Piper Sandler kept a Overweight rating on GILD stock. On October 28, 2022, analysts increased their price target for GILD shares from 74 to 75.

The Average True Range (ATR) for Gilead Sciences Inc. is set at 2.11, with the Price to Sales ratio for GILD stock in the period of the last 12 months amounting to 4.01. The Price to Book ratio for the last quarter was 5.24, with the Price to Cash per share for the same quarter was set at 4.57. Price to Free Cash Flow for GILD in the course of the last twelve months was 20.48 with Quick ratio for the last quarter at 1.20.

GILD Stock Performance Analysis:

Gilead Sciences Inc. [GILD] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 3.25. With this latest performance, GILD shares gained by 10.72% in over the last four-week period, additionally plugging by 41.83% over the last 6 months – not to mention a rise of 26.48% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for GILD stock in for the last two-week period is set at 75.45, with the RSI for the last a single of trading hit 73.44, and the three-weeks RSI is set at 75.06 for Gilead Sciences Inc. [GILD]. The present Moving Average for the last 50 days of trading for this stock 74.87, while it was recorded at 87.70 for the last single week of trading, and 65.19 for the last 200 days.

Insight into Gilead Sciences Inc. Fundamentals:

Operating Margin for any stock indicates how profitable investing would be, and Gilead Sciences Inc. [GILD] shares currently have an operating margin of +37.27 and a Gross Margin at +75.88. Gilead Sciences Inc.’s Net Margin is presently recorded at +22.74.

Return on Equity for this stock inclined to 31.70, with Return on Assets sitting at 9.13.

Gilead Sciences Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.20 and a Current Ratio set at 1.30.


The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for GILD. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Gilead Sciences Inc. go to 1.82%.

Gilead Sciences Inc. [GILD] Insider Position Details

There are presently around $88,588 million, or 82.90% of GILD stock, in the hands of institutional investors. The top three institutional holders of GILD stocks are: BLACKROCK INC. with ownership of 128,460,733, which is approximately 1.2% of the company’s market cap and around 0.09% of the total institutional ownership; VANGUARD GROUP INC, holding 112,087,271 shares of the stock with an approximate value of $9.86 billion in GILD stocks shares; and STATE STREET CORP, currently with $5.21 billion in GILD stock with ownership of nearly 2.232% of the company’s market capitalization.

Positions in Gilead Sciences Inc. stocks held by institutional investors increased at the end of October and at the time of the October reporting period, where 841 institutional holders increased their position in Gilead Sciences Inc. [NASDAQ:GILD] by around 46,921,392 shares. Additionally, 652 investors decreased positions by around 37,797,218 shares, while 217 investors held positions by with 922,194,613 shares. The mentioned changes placed institutional holdings at 1,006,913,223 shares, according to the latest SEC report filing. GILD stock had 106 new institutional investments in for a total of 6,231,871 shares, while 99 institutional investors sold positions of 1,597,828 shares during the same period.


Please enter your comment!
Please enter your name here